MIRA Pharmaceuticals
MIRA
6 hedge funds and large institutions have $102K invested in MIRA Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
2,642% more capital invested
Capital invested by funds: $3.72K → $102K (+$98.3K)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more funds holding
Funds holding: 3 → 6 (+3)
0.65% more ownership
Funds ownership: 0.01% → 0.66% (+0.65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
New York
|
+$96.2K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$52K |
| 3 |
VF
Virtu Financial
New York
|
+$37.2K |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$25.4K |
| 5 |
SSB
Sandy Spring Bank
Olney,
Maryland
|
+$24.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$465 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$116 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GS
1
GTS Securities
New York
| $39.7K | +$96.2K | +37,852 | New |
|
|
2
Northern Trust
Chicago,
Illinois
| $21.5K | +$52K | +20,454 | New |
|
|
VF
3
Virtu Financial
New York
| $15K | +$37.2K | +14,658 | New |
|
|
AWM
4
AE Wealth Management
Topeka,
Kansas
| $10.9K | +$25.4K | +10,000 | New |
|
|
SSB
5
Sandy Spring Bank
Olney,
Maryland
| $10.9K | +$24.6K | +9,700 | +1,437% |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | +$8.89K | +3,500 | New |
|
|
7
JP Morgan Chase
New York
| – | -$465 | -100 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$116 | -25 | Closed |
|
MIRA Hedge Fund Activity: Q4 2023 in Review
6 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q4 2023, worth a combined $102K — up 2,642% from $3.72K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MIRA positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was GTS Securities, opening a new position worth an estimated $96.2K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $465 sold.
- 6 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q4 2023, up from 3 in Q3 2023.
- Funds reported $102K of MIRA Pharmaceuticals stock for Q4 2023, up 2,642% quarter-over-quarter.
- 5 funds opened new MIRA Pharmaceuticals positions in Q4 2023 and 2 closed out, a net change of +3 holders.
- The largest MIRA Pharmaceuticals buyer in Q4 2023 was GTS Securities, an estimated $96.2K added.
- The largest MIRA Pharmaceuticals seller in Q4 2023 was JP Morgan Chase, an estimated $465 sold.
Based on aggregated 13F filings for Q4 2023.